dry%20eye%20syndrome
DRY EYE SYNDROME

Dry eye syndrome is a clinical condition wherein the patient experiences ocular and conjunctival irritation due to decreased tear production and/or excessive tear evaporation.
It is associated with increased osmolarity of the tear film and inflammation of the ocular surface.

Goal of treatments are to relieve symptoms of patients, to improve visual acuity & quality of life of patients, to restore ocular surface & tear film to normal homeostatic state and to correct the underlying defect.

Dry Eye Syndrome Drug Information

Drug Information

Indication: Temporary relief of discomfort due to minor eye irritation from exposure to wind, sun or other irritants. Prot...

GenTeal Gel
carbomer + hypromellose

Indication: Lubricant eye gel for wearers of all types of contact lenses.

Indication: Keratoconjunctival epithelial disorders resulting from Sjogren's & Sicca syndrome (dry eye) & extrinsi...

Indication: Management of acute & chronic anterior uveitis, iridocyclitis, iritis & cyclitis, herpes zoster ophtha...

Tears Naturale Free
dextran 70 + hydroxypropyl methylcellulose

Indication: Relief in both mucin & aqueous deficient dry eye syndromes & symptoms of severe keratoconjunctivitis s...

Tears Naturale II
dextran 70 + hydroxypropyl methylcellulose

Indication: Relief of burning & irritation due to dryness in eyes or exposure to wind or sun. Protectant against furth...

Indication: Vismed/Vismed Multi Lubrication of the eyes in case of dryness, burning sensation & ocular fatigue. Vismed...

Celluvisc
carboxymethylcellulose sodium
1  /  4
Editor's Recommendations
Most Read Articles
4 days ago
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 6 days ago

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

6 days ago
Regardless of treatment, serum hepcidin is elevated in patients with restless leg syndrome (RLS) and may act as a biomarker for this condition, a recent study has found.
Jairia Dela Cruz, 2 days ago
In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.